4640 SW Macadam Avenue
AbSci is a global leader in cutting-edge protein production technologies committed to reducing costs in the biopharmaceutical industry. AbSci’s technology enables dramatic reductions in the cost of producing novel and existing biologics, acceleration of drug discovery timelines, and increased efficiency and flexibility throughout the manufacturing process.
Founders: Mark Valasek and Phil Barish
CEO: Sean McClain
Please click here for AbSci job opportunitites.